Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TM4SF19-TCTEX1D2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | SUPT20H | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | RNF43 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | PSTPIP1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | TFR2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | GRASP | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | OR2B2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | PFDN5 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | C4orf50 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | PTPRZ1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |